pKT-IDH1(R132H)-IRES-Katushka Citations (1)
Originally described in: IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.Nunez FJ, Mendez FM, Kadiyala P, Alghamri MS, Savelieff MG, Garcia-Fabiani MB, Haase S, Koschmann C, Calinescu AA, Kamran N, Saxena M, Patel R, Carney S, Guo MZ, Edwards M, Ljungman M, Qin T, Sartor MA, Tagett R, Venneti S, Brosnan-Cashman J, Meeker A, Gorbunova V, Zhao L, Kremer DM, Zhang L, Lyssiotis CA, Jones L, Herting CJ, Ross JL, Hambardzumyan D, Hervey-Jumper S, Figueroa ME, Lowenstein PR, Castro MG Sci Transl Med. 2019 Feb 13;11(479). pii: 11/479/eaaq1427. doi: 10.1126/scitranslmed.aaq1427. PubMed Journal
Articles Citing pKT-IDH1(R132H)-IRES-Katushka
| Articles |
|---|
| Reprogramming the immune suppressive tumor microenvironment in glioma enhances the efficacy of immune-mediated gene therapy. McClellan BL, Pena Agudelo JA, Mujeeb AA, Dabaja AA, Zhu Z, Raghuram S, Varela ML, Tronrud C, Banerjee K, Wei A, Calatroni C, Zhang LH, Romero LC, Oh P, Alghamri MS, Robbins A, Perricone M, Wang Y, Shay B, Sajjakulnukit P, Lyssiotis CA, Welch JD, Schwendeman A, Lowenstein PR, Castro MG. Mol Ther Oncol. 2026 Apr 21;34(2):201215. doi: 10.1016/j.omton.2026.201215. eCollection 2026 Jun 18. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.